Claim Ownership


Subscribed: 0Played: 0


In this podcast, members of the EAU Guidelines Panel for RCC Prof. Axel Bex (DE)  and Prof. Jens Bedke (DE), discuss renal cell carcinoma (RCC), with updates on treatments and current trials. Prof. Bex and Prof. Bedke talk about what's new in adjuvant treatment for patients with high-risk RCC after radical nephrectomy.  This follows with discussions on the combination and triplet trials, as well as the recent developments in the systemic treatment of advanced RCC.Other topics include cytoreductive surgery, metastasectomy, systemic therapy and observation.  Lastly, Prof. Axel and Prof. Bedke analyse what the role of Stereotactic Body Radiotherapy (SBRT) in advanced RCC might be.  
In this edition we have Dr. Benoît Peyronnet (FR), a Panel Member, and Dr. Néha Sihra (UK), an associate member of the EAU Guidelines Panel for female lower urinary tract symptoms, discussing overactive bladder syndrome (OAB) in women. Ms. Sihra answers questions about what to do when evaluating an overactive bladder patient. She covers the importance of clinical history, and which type of examinations to do, as well as giving details on bladder diaries and symptom scores. More details are given about specific dietary measures and conservative treatments for overactive bladder patients including fluid intake, weight and specific exercises.Ms. Sihra also talks about when to use, and more importantly, when not to use, various medications. And lastly, she looks at what the alternatives are for patients who fail first line treatments. 
In this podcast, EAU Guidelines office member, Prof. Philip Cornford (GB), and Prostate Cancer Panel patient representative, Dr. Erik Briers (BE),  share their views on the importance of patient input in authoring the EAU Guidelines.Our discussants review the relationship between specialists and their patients, and how they can create better advocacy, as well as, increased involvement going forward in writing the guidelines. 
In this edition, Prof. Christian Radmayr talks about the importance of the dissemination of the EAU Guidelines. Prof. Christian Radmayr is a member of the Paediatric Urology Guidelines Panel and chair of this panel since 2018. In this episode he touches on the various platforms through which the EAU Guidelines are disseminated, which initatives have the most impact and how clear communication of medical guidelines is vital in the current digital climate.
In this podcast, Prof. Peter Gilling (NZ), Professor of Surgery at the University of Auckland, shares details with us on the main findings of the WATER study. Prof. Gilling gives us some insights into the five-year results of the WATER study, a pivotal trial that compares Aquablation versus transurethral resection of the prostate (TURP). The results were presented at the 2022 EAU Annual Congress. He also identifies the ideal patients for Aquablation, what steps of the procedure could be improved with this technique, and looks at the future of the Aquablation technique.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates.
In this edition, we have Prof. Tamsin Greenwell (GB), a panel member on the EAU Guidelines Panel for Urethral Strictures, discussing the management of female urethral stricture disease. Prof. Greenwell begins with an overview on the causes of female urethral strictures and how a diagnosis should be made. Following this she answers questions on treatment options, including what type of urethroplasty to use (dorsal and ventral), and which tissue is best for substitution.  She reports on the outcomes of female urethroplasty, and concludes with a discussion on adverse effects from tissue harvest for use in substitution urethroplasty. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates.
In this podcast, Dr. Vasileios Sakalis (GR), a member of the EAU Guidelines Panel for Male Lower Urinary Tract Symptoms, reports on the new section in the guidelines relating to Male Urinary Incontinence.Dr Vasileios Sakalis begins with information on an important addendum to the 2022 Male LUTS Guidelines with regard to the new incontinence section, and the reasons why this new section has been included in Male LUTS. He talks about an important study that has been included in this section, as well as updates in the pharmacological management of Male LUTS.  Lastly, Dr Sakalis shares his knowledge on novelties in the diagnostic evaluation of male patients with Lower Urinary Tract Symptoms. For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates.
In this commentary, Assoc. Prof. Fardod O'Kelly (IE), member of the EAU Guidelines Panel for paediatric urology, shares his expert knowledge on nocturnal enuresis, also known as bedwetting.Assoc. Prof. O'Kelly begins by answering questions on the prevalence of bedwetting among children, teenagers and into adulthood. More details are given to define this heritable condition, as well as covering the non-genetic risk factors.Making a correct diagnosis can be challenging, and the condition is often mis-diagnosed, but Assoc. Prof. O'Kelly discusses how to make a good diagnosis.Lastly, the different management strategies are reviewed.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates.
Professors Giulio Del Popolo and Gilles Karsenty (panel members), are joined by Dr. Stefania Musco (associate member) of the EAU Guidelines Panel for Neuro-urology, to talk about N-SUI.In this commentary three experts share their knowledge of neurogenic stress urinary incontinence (N-SUI); from surgical management, urodynamic evaluation, bulking agents, and other treatments, including artificial sphincter. Prof. Giu lio Del Popolo (IT) begins with an explanation to the surgical management of N-SUI and assesses why it is considered such a challenge. Following this, Dr. Stefania Musco (IT) reviews the importance of urodynamic in neurogenic stress urinary incontinence. Is there a place for bulking agents? And if so, in which patients? Prof. Giulio Del Popolo analyses the use of  autologous sling or synthetic mid-urethral tape for treating female neurogenic stress urinary incontinence? Lastly, Prof. Gilles Karsenty (FR) gives his assessment on who the best candidates for artificial sphincter are. 
Dr. Sajjad Rahnama'i (NL), a member of the EAU Section of Female & Functional Urology, will discuss neurogenic detrusor overactivity, including its diagnosis and treatment.Several questions will be answered. What is neurogenic detrusor overactivity, and can it be a serious condition? What is the standard diagnostic workup of a patient in whom we suspect neurogenic detrusor overactivity? What is the first line treatment of neurogenic detrusor overactivity? What are the second- and third-line treatments? And lastly, how should patients with neurogenic detrusor overactivity be followed up, and by whom?This podcast is supported by an unrestricted education grant from Medtronic.For more EAU podcasts, please subscribe to our podcast channel for regular updates.
Dr. Richard Cathomas, medical oncologist from Zurich in Switzerland discusses Immunotherapy in muscle-invasive bladder cancer.He goes into the mechanism of action of immunotherapy and why could it work well in bladder cancer. Where do we currently stand with the use of immunotherapy in the NEOADJUVANT setting of muscle invasive bladder cancer? And what is currently the best place to integrate immunotherapy for METASTATIC bladder cancer?Prof. Dr.  Cathomas closes with the answer to the question of why some patients benefit much more than others from immunotherapy. Prof. Dr. Richard Cathomas is oncologist panel member on the EAU Guidelines for muscle-invasive bladder cancer.
In this second edition of two updates, Professor Nicolas Mottet, the chair of the EAU Guidelines panel for prostate cancer, discusses which are the most important changes and new recommendations in the new EAU Guidelines for prostate cancer for 2022 relating to treatment approaches.
In this first edition of two updates, Professor Nicolas Mottet, the chair of the EAU Guidelines panel for prostate cancer, highlights the work of the panel.His talk includes new systematic reviews, and outlines which are the most important changes in the new EAU Guidelines for prostate cancer for 2022 relating to the definition of clinically localized and clinically significant prostate cancer, diagnostic evaluation, particularly transperineal biopsy. Professor Nicolas Mottet also discusses key points relating to staging and imaging.
What exactly is pain? What do I have to know about pain if I am treating patients with chronic pelvic pain? What is necessary to diagnose a chronic pelvic pain syndrome? What factors are key to successfully treat patients with a chronic pelvic pain syndrome? And what are the psychological aspects of chronic pain? Prof Daniel Engeler answers these questions.Prof Engeler is chairman of the EAU Guidelines panel on Chronic Pelvic Pain.
Dr Bela Köves answers questions about the changes in the guidelines chapter of recurrent urinary tract infections. And in particular, he elaborates on the question, what  the most important updates are for the specific preventive approaches. Are there any changes regarding lifestyle advices or behavioral modifications? The second part of the podcast covers the updates about the use of topical oestrogen, immunoactive prophylaxis, the changes about prophylaxis with probiotics and cranberries. Dr Bela Köves is a member of the EAU Guidelines panel on urological infections. 
In this edition, we have Professor Berk Burgu, a member of the EAU Guidelines panel for Paediatric Urology, discussing vesico-ureteral reflux in children, including its diagnosis and treatment. We get answers to the question what is vesico-ureteral reflux is and Prof. Burgu explains the importance.  Should we treat vesico-ureteral reflux immediately after being diagnosed? Is there a structured diagnostic work-up for vesico-ureteral reflux? In the last part of the podcast, Prof. Burgu discusses the options for the surgical treatment of reflux. 
In this edition, we have Dr. Toine van der Heijden discussing the three different diversions mentioned in the guideline after cystectomy - uretero cutaneostomy, ileal conduit and an orthotopic neobladder – along with the reasons for choosing a certain diversion and helping the patient to decide.Dr. Toine van der Heijden is a member of the EAU Guidelines panel for Muscle Invasive Bladder Cancer.
The new guidelines on Non-neurogenic Female LUTS have replaced the old Urinary Incontinence Guideline. Dr. Arjun Nambiar discusses the thought process behind this and tells what's new. He also goes deeper into the process that guidelines users or readers may not be aware of.Dr. Arjun Nambiar is member of the EAU Guidelines panel for non-neurogenic Female LUTS.
Dr. Sachin Malde catches up with us about the current status and future challenges in minimally invasive treatments for BPO. He elaborates on the surgical options and the EAU guidelines recommendations about the newer surgical treatments for BPO.We also gain insight into the criteria the guidelines panel use to make a recommendation about a particular treatment. And finally, Dr. Malde discuss the future developments that he think will help to strengthen the recommendations made by the EAU guidelines in this area.Dr. Sachin Malde is an associate member of the EAU Guidelines panel on Management of Non-neurogenic Male LUTS.
How can we improve the organ pool for kidney transplantation and how do we implement all alternatives in the current transplant teams? Dr. Oscar Rodriguez Faba is an associate member of the EAU Guidelines panel for kidney transplantation and talks about these questions in this podcast.Oscar Rodriguez Faba closes with the answer to the question if the results are comparable to cadaveric donors and conventional living donors.
Download from Google Play
Download from App Store